How has been the historical performance of Mukka Proteins?

Answer:The historical performance of Mukka Proteins shows significant fluctuations in key financial metrics over the past four years. Breakdown: Mukka Proteins reported net sales of 1,006.42 Cr in March 2025, a decrease from 1,379.83 Cr in March 2024 and 1,177.12 Cr in March 2023, but an increase from 770.50 Cr in March 2022. The total operating income mirrored this trend, reaching 1,006.42 Cr in March 2025. The total expenditure, excluding depreciation, was 911.53 Cr in March 2025, down from 1,274.36 Cr in March 2024, indicating improved cost management. Operating profit (PBDIT) was 110.01 Cr in March 2025, a decline from 121.79 Cr in March 2024 but an increase from 92.85 Cr in March 2023. Profit before tax decreased to 59.20 Cr in March 2025 from 84.35 Cr in March 2024, while profit after tax was 47.03 Cr, down from 71.20 Cr in the previous year. The consolidated net profit for March 2025 was 46.46 Cr, compared to 70.05 Cr in March 2024. The company’s total assets grew to 1,076.32 Cr in March 2025 from 940.79 Cr in March 2024, while total liabilities also increased to 1,076.32 Cr from 940.79 Cr. Cash flow from operating activities remained negative at -111.00 Cr in March 2025, although it improved from -150.00 Cr in March 2024. Overall, Mukka Proteins has experienced a mix of growth in sales and assets, but profitability has faced challenges in recent years.